Oualid Talhi

Dr. Oualid Talhi

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Journal of Molecular Structure
Verified
Journal Article
Closed access
ADAmar Djemoui
Amar Djemoui
ANAbdelkader Naouri
Abdelkader Naouri
MOMohammed Ridha Ouahrani
Mohammed Ridha Ouahrani
DDDjamila Djemoui
Djamila Djemoui
SLSouli Lahcene
Souli Lahcene
Artur M. S. SilvaArtur M. S. Silva
Artur M. S. Silva

16 October 2018 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MBMohammed Benabdallah
Mohammed Benabdallah
OTOualid Talhi
Oualid Talhi
FNFatiha Nouali
Fatiha Nouali
Noureddine Choukchou-BrahamNoureddine Choukchou-Braham
Noureddine Choukchou-Braham
BKBachari Khaldoun
Bachari Khaldoun
ASArtur M. S. Silva
Artur M. S. Silva
The present review deals with the progress in medicinal chemistry of spirocyclic compounds, a wider class of natural and synthetic organic molecules, defined as a hybrid of two molecular entities covalently linked via a unique tetrahedral carbon. This spiro central carbon confers to the molecules a tridimensional structurally oriented framework, which is found in many medicinally relevant compounds, a well-known example is the antihypertensive spironolactone. Various bioactive natural products possess the privileged spiro linkage and different chemo-types thereof become synthetically accessible since the 20th century. Actually, there has been a growing interest in the synthesis of heterocyclic hybrids gathered via a spiro carbon. Most of these combinations are two moieties in one scaffold being able to interfere with biological systems through sequential mechanisms. Spirocyclic hybrids containing indole or oxindole units are compounds exhibiting higher interaction with biological receptors by protein inhibition or enzymatic pathways and their recognition as promising anticancer agents in targeted chemotherapy is foreseen. These specific, low-weight and noncomplex spirocyclic hybrids are potent inhibitors of SIRT1, Mdm2–p53 and PLK4, showing affinity for anaplastic lymphoma kinase (ALK) receptor. They are also known as excellent DNA binders, acting on cellular division by arresting the cell cycle at different phases and inducing apoptotic cell death. A structural diversity of spirocyclic hybrids has proved neuroprotective effects, anti-HIV, antiviral and antibacterial activities. Hundred of papers are mentioned in this review underlying chemical issues and pharmacological potencies of spiro compounds, which render them impressive synthetic hits for innovative drug conception.

18 September 2013 in MedChemComm
Verified
Journal Article
Closed access
PDF file
Clemens ZwergelClemens Zwergel
Clemens Zwergel
SVSergio Valente
Sergio Valente
ASAngela Salvato
Angela Salvato
ZXZhanjie Xu
Zhanjie Xu
OTOualid Talhi
Oualid Talhi
Gilbert KirschGilbert Kirsch
Gilbert Kirsch
Not widely distributed in nature, aurones, (Z)-2-benzylidene-benzofuran-3(2H)-ones, are one of the less common and lesser-known representatives of a flavonoid subclass. Nevertheless, they exhibit a strong and broad variety of biological activities. We have combined the benzofuranone part of a classical aurone with either a chromone or a coumarin scaffold which proved to feature interesting biological activities including antimicrobial, antiviral, anticancer, anti-inflammatory and antioxidant properties. Herein we present a series of 26 novel benzofuran derivatives with the first biological results in K562 human leukemia cells showing that compounds 21b, 29b and 29c are able to induce around 24% apoptosis.

1 March 2018 in Cancer Letters
Verified
Journal Article
Closed access
JLJin-Young Lee
Jin-Young Lee
OTOualid Talhi
Oualid Talhi
DJDongman Jang
Dongman Jang
CCClaudia Cerella
Claudia Cerella
AGAnthoula Gaigneaux
Anthoula Gaigneaux
MDMarc Diederich
Marc Diederich

15 January 2016 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
OTOualid Talhi
Oualid Talhi
LBLidia Brodziak‐Jarosz
Lidia Brodziak‐Jarosz
JPJana Panning
Jana Panning
BOBarbora Orlikova
Barbora Orlikova
Clemens ZwergelClemens Zwergel
Clemens Zwergel
Artur M. S. SilvaArtur M. S. Silva
Artur M. S. Silva

1 December 2018 in Cancer Letters
Verified
Journal Article
Closed access
AMAloran Mazumder
Aloran Mazumder
JLJin-Young Lee
Jin-Young Lee
OTOualid Talhi
Oualid Talhi
CCClaudia Cerella
Claudia Cerella
SCSébastien Chateauvieux
Sébastien Chateauvieux
MDMarc Diederich
Marc Diederich